Filing Details

Accession Number:
0001144204-14-043834
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-21 11:06:53
Reporting Period:
2014-06-10
Filing Date:
2014-07-21
Accepted Time:
2014-07-21 11:06:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453593 Bacterin International Holdings Inc. BONE Biological Products, (No Disgnostic Substances) (2836) 205313323
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1508205 Lee Darrel Holmes 664 Cruiser Lane
Belgrade MT 59714
Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-06-10 50,000 $0.74 11,656 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Disposition 2014-07-18 70,000 $0.00 70,000 $2.36
Common Stock Employee Stock Option Disposition 2014-07-18 100,000 $0.00 100,000 $1.65
Common Stock Employee Stock Option Disposition 2014-07-18 30,000 $0.00 30,000 $1.34
Common Stock Employee Stock Option Disposition 2014-07-18 18,287 $0.00 18,287 $1.50
Common Stock Employee Stock Option Disposition 2014-07-18 11,712 $0.00 11,712 $1.50
Common Stock Employee Stock Option Disposition 2014-07-18 15,000 $0.00 15,000 $1.50
Common Stock Employee Stock Option Disposition 2014-07-18 15,000 $0.00 15,000 $1.50
Common Stock Employee Stock Option Disposition 2014-07-18 15,000 $0.00 15,000 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-03-27 No 4 D Direct
0 2022-09-06 No 4 D Direct
0 2016-10-09 No 4 D Direct
0 2009-12-29 2018-12-29 No 4 D Direct
0 2010-12-29 2018-12-29 No 4 D Direct
0 2011-12-29 2018-12-29 No 4 D Direct
0 2012-12-29 2018-12-29 No 4 D Direct
0 2013-12-29 2018-12-29 No 4 D Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.76, inclusive. The reporting person undertakes to provide to Bacterin International Holdings, Inc. ("BONE"), any shareholder of BONE, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option was canceled by mutual agreement of the reporting person and the issuer. The reporting person received $1.00 as consideration for the cancellation of all options listed in this Form 4.
  3. The option provided for vesting in five equal annual installments beginning March 27, 2013.
  4. The option provided for vesting in three equal annual installments beginning September 6, 2013.
  5. The option provided for vesting in two equal annual installments beginning 10/9/07.